You have 9 free searches left this month | to do more

Dasatinib

Dasatinib is a drug used to treat Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Leukemia, and other conditions. Dasatinib is being actively studied in 66 studies and prior, has been studied in 113.

Top SponsorsTop SitesTop Investigators
Bristol-Myers SquibbLocal InstitutionStephen Spurgeon
National Cancer Institute (NCI)M D Anderson Cancer CenterAbhinav Deol
M.D. Anderson Cancer CenterCity of Hope Comprehensive Cancer CenterPhilip C. Amrein, M.D.
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Dasatinib
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-03-22
Mar 22, 2022
S
Recruiting
  • Dasatinib
  • +2 more
  • Dasatinib
  • Shenzhen, Guangdong, China
    Xin Du
2022-03-15
Mar 15, 2022
M
Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Dasatinib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-19
Jan 19, 2022
B
Active, not recruiting
  • Multiple Indications Cancer
  • Dasatinib
  • Besancon, France
  • +5 more
2021-12-02
Dec 2, 2021
N
Completed
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
M
Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Dasatinib
  • Decitabine and Cedazuridine
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-29
Dec 29, 2021
M
Active, not recruiting
  • Malignant Pleural Mesothelioma
  • Dasatinib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-02-25
Feb 25, 2022
G
Completed
  • Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
  • dasatinib
  • Valencia, Spain
    Hospital La Fe
2022-03-16
Mar 16, 2022
N
Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Dasatinib
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
2021-12-15
Dec 15, 2021
M
Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Dasatinib
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-05
May 5, 2021
S
Recruiting
  • Chronic Myeloid Leukemia in Chronic Phase
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
2022-03-15
Mar 15, 2022
U
Terminated
  • Breast Neoplasms
  • Triple Negative Breast Neoplasms
  • Dasatinib
  • +2 more
  • Chicago, Illinois
  • +1 more
2022-01-31
Jan 31, 2022
N
Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Inflammatory Carcinoma
  • Dasatinib
  • Icosapent Ethyl
  • (no location specified)
2022-03-11
Mar 11, 2022
O
Completed
  • Refractory Chronic Lymphocytic Leukemia
  • +4 more
  • Dasatinib
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
2021-03-15
Mar 15, 2021
C
Active, not recruiting
  • EGFR Gene Mutation
  • Nonsmall Cell Lung Cancer
  • Washington, District of Columbia
  • +1 more
2022-01-09
Jan 9, 2022
L
Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
2021-10-07
Oct 7, 2021
M
Completed
  • Breast Cancer
  • Bone Metastases
  • Dasatinib
  • Zoledronic Acid
  • Chicago, Illinois
  • +2 more
2022-02-02
Feb 2, 2022
H
Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Dasatinib
  • Amman, Jordan
  • +4 more
2022-01-17
Jan 17, 2022
U
Completed
  • Pancreatic Cancer Metastatic
  • Gainesville, Florida
    UF Health Cancer Center
2020-12-03
Dec 3, 2020
I
Active, not recruiting
  • Acute,Leukemia, Lymphoid
  • Dasatinib
  • +12 more
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
2021-02-08
Feb 8, 2021
F
Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • +2 more
  • Dasatinib
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
2021-09-29
Sep 29, 2021
B
Completed
  • Leukemia
  • Dasatinib
  • Vienna, Austria
  • +12 more
2021-02-24
Feb 24, 2021